Skip to main content
Caplight Logo









Path Fertility

Path Fertility

Private
Salt Lake City, UtahHealthcare & Life Scienceshttps://pathfertility.com/

Last Round

VC Round

Apr 6, 2026

Total Funding Raised

$8.2M

Company Overview

Path Fertility is a biotechnology company that provides an epigenetic sperm quality test called SpermQT to diagnose male infertility.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Healthcare Analytics, Telemedicine

Business Model

B2B2C

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

male infertility diagnosissperm quality testepigenetic diagnosticsat-home fertility testmale factor infertilityunexplained infertilityDNA methylation analysisfertility techAI diagnosticsDTC diagnosticssemen analysisreproductive healthazoospermiafertility benefits

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Path Fertility Comparables

Compare Path Fertility with similar companies based on industry and business-model similarity.

Path Fertility comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Androvia LifeSciences
83%
Mojo Fertility
79%
Posterity Health
79%

Path Fertility Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundApr 6, 2026
SeedFeb 17, 2021

Key People

Founding team and executive leadership

Kristin Brogaard

Co-Founder And Chief Scientific Officer

Founding Team

Andy Olson

Co-Founder, CEO

Founding Team

Path Fertility Investors

Notable investors and investment history

Path Fertility investors
InvestorRounds
Fuel AcceleratorSeed
Rhythm Venture CapitalSeed
Park City AngelsSeed
KickstartSeed
MedMountain VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2024

    Grew 300% QoQ from 1 to 4 employees.

  • Feb 17, 2021

    $8.2M round led by Kickstart and MedMountain Ventures.

Path Fertility Filings

Explore SEC and related filing metadata, where available.

Path Fertility filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Path Fertility's valuation, stock price, and market status.

Is Path Fertility a public or private company?

Path Fertility is a private company.

What is the current stock price of Path Fertility?

Path Fertility is a private company with no public stock price. No recent secondary market data is available.

How much is Path Fertility worth (valuation)?

Valuation information for Path Fertility is not publicly available.

Can I buy Path Fertility stock?

Path Fertility shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Path Fertility's last funding round?

Funding round information for Path Fertility is not publicly available.

Who are the main investors in Path Fertility?

Investor information for Path Fertility is not publicly disclosed.

Will Path Fertility IPO soon?

No public IPO plans have been announced for Path Fertility.

How can I track Path Fertility secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Path Fertility's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSalt Lake City, Utah
Employee Range4
Year Founded2019
Last FundingApr 6, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?